5 Nephrology Headlines You Missed in February 2026

The nephrology field continued to see advances in February 2026, with MAJESTY and TACITO trial updates, key insights into KDIGO guidelines for IgA Nephropathy (IgAN), along with featured content for Rare Disease Day and a 1-year look back at semaglutide (Ozempic) for chronic kidney disease (CKD) and type 2 diabetes (T2D).